Umbilical cord blood transplantation and the impact of the CTLA4 genotype on outcomes.

Umbilical cord blood transplantation and the impact of the CTLA4 genotype on outcomes. Expert Rev Hematol. 2019 Oct 12;: Authors: Szostak B, Machaj F, Rosik J, Pawlik A Abstract Background: Umbilical cord blood transplantation is an effective method of curing multiple diseases when there is no donor available for allogenic hematopoietic stem cell transplantation (AHSCT). It has been recently suggested that polymorphisms in genes affecting antigen presentation could potentially affect cord blood transplantation (CBT) outcomes. Areas covered: In this review we present the results of the latest studies investigating the link between CTLA4 gene variability and umbilical cord blood transplantation outcomes. Expert opinion: The search for genetic variants that influence the immune response, both innate and adaptive immunity, may lead to more optimal therapies. Promising candidate genes are those that regulate the expression of proteins associated with T-cell activation. Many genetic variants could be therapeutically important, including those related to innate and adaptive immunity, cytokines, chemokines, drug metabolizing enzymes, drug transporters, and inflammatory enzymes. The development of an algorithm that includes the determination of selected genetic variants could be helpful for appropriate donor-recipient CBT matching. PMID: 31607188 [PubMed - as supplied by publisher]
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research